Pharmapolymers in the 21st century: Synthetic polymers in drug delivery applications

被引:175
作者
Englert, Christoph [1 ,2 ]
Brendel, Johannes C. [1 ,2 ]
Majdanski, Tobias C. [1 ,2 ]
Yildirim, Turgay [1 ,2 ]
Schubert, Stephanie [2 ,3 ]
Gottschaldt, Michael [1 ,2 ]
Windhab, Norbert [4 ]
Schubert, Ulrich S. [1 ,2 ]
机构
[1] Friedrich Schiller Univ Jena, Lab Organ & Macromol Chem IOMC, Humboldtstr 10, D-07743 Jena, Germany
[2] Friedrich Schiller Univ Jena, JCSM, Philosophenweg 7, D-07743 Jena, Germany
[3] Friedrich Schiller Univ Jena, Dept Pharmaceut Technol & Biopharm, Lessingstr 8, D-07743 Jena, Germany
[4] Evon Nutr & Care GmbH, Kirschenallee, D-64293 Darmstadt, Germany
关键词
Pharmapolymers; Drug delivery; Market; Clinical trials; Structure-activity relationships; RING-OPENING POLYMERIZATION; BARE-METAL STENTS; PHASE-III TRIAL; MOLECULAR-WEIGHT POLYACRYLONITRILE; SYSTEMICALLY ADMINISTERED SIRNA; TRANSFER RADICAL POLYMERIZATION; CONTROLLED-RELEASE FORMULATION; PACLITAXEL POLIGLUMEX CT-2103; ETIRINOTECAN PEGOL NKTR-102; LINKED POLY(VINYL ALCOHOL);
D O I
10.1016/j.progpolymsci.2018.07.005
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
The administration of drugs, as a main challenge of pharmaceutical and medicinal applications, has certainly benefited from the application of synthetic polymers. However, despite an enormous effort to develop new materials for drug delivery applications, only few of them have entered the market due to the hurdles of regulation, production, cost efficiency and both industrial's and patients' acceptance. In this review, we summarize all these classes of synthetic polymers, which are on the market as well as the latest developments in clinical trials, and describe their application in polymer-drug conjugates, as excipients, in nano-/microscopic and macroscopic drug carriers, as polymeric coatings, or as polymeric drugs. Our intention is to create a link between the underlying chemical structures, the properties of the polymers, and their area of application, where they are often just known by their trade names or abbreviations. In addition selected types of synthetic polymers are highlighted that feature interesting properties and have the potential to make it to the market in future. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:107 / 164
页数:58
相关论文
共 727 条
[21]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[22]   Controlled release of therapeutics using interpenetrating polymeric networks [J].
Aminabhavi, Tejraj M. ;
Nadagouda, Mallikarjuna N. ;
More, Uttam A. ;
Joshi, Shrinivas D. ;
Kulkarni, Venkatrao H. ;
Noolvi, Malleshappa N. ;
Kulkarni, Padmakar V. .
EXPERT OPINION ON DRUG DELIVERY, 2015, 12 (04) :669-688
[23]   Polyethersulfone/polyacrylonitrile blend ultrafiltration membranes with different molecular weight of polyethylene glycol: preparation, morphology and antifouling properties [J].
Amirilargani, Mohammad ;
Sabetghadam, Anahid ;
Mohammadi, Toraj .
POLYMERS FOR ADVANCED TECHNOLOGIES, 2012, 23 (03) :398-407
[24]   Mucoadhesive polymeric platforms for controlled drug delivery [J].
Andrews, Gavin P. ;
Laverty, Thomas P. ;
Jones, David S. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 71 (03) :505-518
[25]   A review of copolymerization of green house gas carbon dioxide and oxiranes to produce polycarbonate [J].
Ang, Rui-Ren ;
Sin, Lee Tin ;
Bee, Soo-Tueen ;
Tee, Tiam-Ting ;
Kadhum, A. A. H. ;
Rahmat, A. R. ;
Wasmi, Bilal A. .
JOURNAL OF CLEANER PRODUCTION, 2015, 102 :1-17
[26]  
[Anonymous], 2015, CIPLAMED ONCODOX PEG
[27]   An overview of clinical and commercial impact of drug delivery systems [J].
Anselmo, Aaron C. ;
Mitragotri, Samir .
JOURNAL OF CONTROLLED RELEASE, 2014, 190 :15-28
[28]   Synthesis and assembly of amphiphilic tadpole-shaped block copolymers based on poly(amido amine) dendrimer [J].
Aoi, K ;
Motoda, A ;
Ohno, M ;
Tsutsumiuchi, K ;
Okada, M ;
Imae, T .
POLYMER JOURNAL, 1999, 31 (11) :1071-1078
[29]   A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer®) in recurrent ovarian cancer:: A Gynecologic Oncology Group study [J].
Armstrong, Deborah K. ;
Fleming, Gini F. ;
Markman, Maurie ;
Bailey, Howard H. .
GYNECOLOGIC ONCOLOGY, 2006, 103 (02) :391-396
[30]  
Arsalani N, 2009, IRAN POLYM J, V18, P623